Caplin Point Laboratories Limited (BSE:524742)will look for acquisitions. Paarthipan Chellappan, Chairman, said during the Fourth Quarter Fiscal Year '24 Earnings Conference Call, "You know the saying, people always say top line is vanity, bottom line is sanity, cash is King. And we keep the cash actually for future acquisition.

If suppose if you come -- in case if you come across a meaningful acquisition, that will definitely increase actually our top line and bottom line and cash flow also. That's one of the reasons we, in fact, whatever cash which we generate in the form of additional cash, it gets accumulated over a period of time. Side by side, we are also completing the projects.

And this is not only used for what we call project completion, but also when we group our various products such as biological products and all, that involves a lot of money in the form of Phase III clinical trials, we'll be using it for that also. On top of it, as I told you, this will be used mainly for the meaningful acquisition at a later date".